Will neratinib (neratinib) enter medical insurance in 2024?

Neratinib (Neratinib) is an oral anti-tumor drug that belongs to the category of targeted therapy drugs. It is used to treat breast cancer, specifically a specific subtype called HER2-positive breast cancer. HER2 (human epidermal growth factor receptor 2) is a protein that contributes to the development of breast cancer by promoting the growth and division of cancer cells. Therefore, HER2positive breast cancer is a type of cancer that is relatively dependent on the HER2 signaling pathway.

Neratinib (neratinib) has been launched in the domestic market and has been included in the coverage of medical insurance. Patients can purchase it directly in the country, and the cost is about 7,000 to 8,000 yuan. For specific prices and detailed policies on medical insurance reimbursement, please consult your local hospital pharmacy. If you are looking for a more economical option, the price of generic drugs in Bangladesh is relatively affordable, only about more than 3,000 yuan, which is nearly half the price of the domestic market, and its drug ingredients are basically the same as the domestic version.

The mechanism of action of neratinib is to block the growth and spread of tumor cells by inhibiting the activity of HER2 and other related signaling pathways. Unlike traditional chemotherapy drugs, targeted drugs such as neratinib are more targeted and can more precisely intervene in the survival signals of cancer cells, thereby reducing damage to healthy tissues.

Neratinib (neratinib) is usually taken as an oral, once-daily medication to treat early-stage or metastatic HER2-positive breast cancer. In the treatment of early-stage breast cancer, it is often used after surgery and/or radiation therapy to reduce the risk of cancer recurrence. For metastatic breast cancer, neratinib (neratinib) may be available as first-line treatment or as a subsequent treatment option.

However, although neratinib has shown significant efficacy in the treatment of breast cancer, it may also cause some side effects. Common side effects include diarrhea, rash, digestive problems such as nausea and vomiting, as well as fatigue, headache, etc. In addition, neratinib (neratinib) may cause serious cardiotoxicity, so cardiac function needs to be monitored closely during use.